Format

Send to

Choose Destination
Neuroscience. 2013 Nov 12;252:489-500. doi: 10.1016/j.neuroscience.2013.07.052. Epub 2013 Jul 30.

Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice.

Author information

1
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, United States.

Abstract

Hemorrhagic stroke, including intracerebral hemorrhage (ICH), is a devastating subtype of stroke; yet, effective clinical treatment is very limited. Accumulating evidence has shown that mild to moderate hypothermia is a promising intervention for ischemic stroke and ICH. Current physical cooling methods, however, are less efficient and often impractical for acute ICH patients. The present investigation tested pharmacologically induced hypothermia (PIH) using the second-generation neurotensin receptor (NTR) agonist HPI-201 (formerly known as ABS-201) in an adult mouse model with ICH. Acute or delayed administrations of HPI-201 (2mg/kg bolus injection followed by 2 injections of 1mg/kg, i.p.) were initiated at 1 or 24h after ICH. HPI-201 induced mild hypothermia within 30 min and body and brain temperatures were maintained at 32.7 ± 0.4°C for at least 6h without causing observable shivering. With the 1-h delayed treatment, HPI-201-induced PIH significantly reduced ICH-induced cell death and brain edema compared to saline-treated ICH animals. When HPI-201-induced hypothermia was initiated 24h after the onset of ICH, it still significantly attenuated brain edema, cell death and blood-brain barrier breakdown. HPI-201 significantly decreased the expression of matrix metallopeptidase-9 (MMP-9), reduced caspase-3 activation, and increased Bcl-2 expression in the ICH brain. Moreover, ICH mice received 1-h delayed HPI-201 treatment performed significantly better in the neurological behavior test 48 h after ICH. All together, these data suggest that systemic injection of HPI-201 is an effective hypothermic strategy that protects the brain from ICH injury with a wide therapeutic window. The protective effect of this PIH therapy is partially mediated through the alleviation of apoptosis and neurovascular damage. We suggest that pharmacological hypothermia using the newly developed neurotensin analogs is a promising therapeutic treatment for ICH.

KEYWORDS:

ABS-201; BBB; CNS; HPI-201; ICH; INTERACT; Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage; MMP-9; NSS; NT; NTR; PBS; PIH; SDS–PAGE; TBS-T; TUNEL; Tween in Tris-buffered saline; blood–brain barrier; central nervous system; intracerebral hemorrhage; matrix metallopeptidase-9; neurological stroke scale; neurotensin; neurotensin receptor; pharmacological hypothermia; pharmacologically induced hypothermia; phosphate-buffered saline; rTdT; sodium dodecyl sulfate–polyacrylamide gel electrophoresis; tPA; terminal deoxynucleotidyl transferase dUTP nick end labeling; terminal deoxynucleotidyl transferase recombinant enzyme; tissue plasminogen activator

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center